UBC-led study offers lessons for other nations on deregulating mifepristone
UNIVERSITY OF BRITISH COLUMBIA, Research News
NEWS RELEASE 14-SEP-2020
Removing restrictions on how mifepristone--the medical abortion drug--can be prescribed and dispensed in Canada greatly improved access to abortion, especially in rural communities across the country.
That's one of
the key findings of new University of British Columbia-led research published
today in the Annals of Family Medicine.
Ontario, New Brunswick violating Canada Health Act by forcing patients to pay for abortions: National Abortion Federation
Carly Weeks, Health Reporter
Updated July 16, 2019
New Brunswick and Ontario are violating a federal health law by forcing patients to pay for their abortions, and Ottawa must act to remove those barriers, according to the head of the National Abortion Federation.
The New Brunswick government doesn’t pay for surgical abortions performed outside of hospitals, meaning patients at a private clinic in Fredericton must pay $700 to $850, according to the clinic website. The only other abortion clinics in New Brunswick are in Bathurst and Moncton. They are in hospitals and receive public funds, but are several hours from Fredericton by car. Many parts of the province have no abortion clinic nearby.
Mifegymiso Can Be Prescribed Without An Ultrasound: Health Canada
"Health care practitioners across Canada have been asking for removal for this restriction."
By Maija Kappler
Apr 17, 2019
Canadian doctors are no longer required to perform an ultrasound before prescribing medicine that will end unwanted pregnancies. Experts say the change will eliminate a significant barrier to abortion access, particularly for women living in rural areas who often had to travel major distances or wait long periods of time before they could get ultrasounds.
Health Canada made the announcement that an ultrasound was no longer required before a doctor could prescribe Mifegymiso, the "abortion pill," in a press release on Tuesday.
Abortion-pill inequality: How access varies widely across Canada
Two years after Canadians got access to Mifegymiso, some regions have seen thousands of prescriptions, but others have had hardly any, according to figures obtained by The Globe and Mail. The numbers point to deeply rooted problems in regional abortion care
October 12, 2018
Women’s health advocates have hailed the abortion pill as the key to eliminating barriers to abortion in Canada because it can be prescribed by a family doctor and taken at home, no matter where a woman lives. Yet, nearly two years after Mifegymiso became available, many women still have to travel to abortion clinics, endure lengthy waits and pay out-of-pocket if they want to use it to end their pregnancies.
Prescribing data provided to The Globe and Mail show large regional disparities in access to the abortion pill, which the World Health Organization says is a safe and effective method of terminating pregnancies in the first nine weeks. In Manitoba, where nearly 4,000 abortions are performed every year, no prescriptions for Mifegymiso have been dispensed from retail pharmacies since it came on the market, according to the data. But in Ontario, which has about 40,000 abortions every year, more than 6,600 prescriptions were dispensed last year and this year, up to August, 2018.
Health Canada approves abortion pill use up to nine weeks
Update to product monograph comes after health advocates warned current rules too restrictive
Kyle Duggan and Amanda Connolly
Tuesday, November 7th, 2017
Women seeking an abortion in Canada will now be able to use the abortion pill up to nine weeks into a pregnancy.
Health Canada updated its product monograph for Mifegymiso, the two-drug combination of pills that doctors can prescribe to women who want a medical abortion. The current monograph, approved in July 2015 after years of delays, states that Mifegymiso is safe for use up to seven weeks into a pregnancy — even though most countries that have legalized the abortion pill use a 10-week limit.
Canada responds to claims that aborted babies are left to die alone
Ellen Coyne, Senior Ireland Reporter
October 24 2017, The Times
The Canadian authorities addressed claims from anti-abortion politicians in Ireland that the country’s laws resulted in babies being left to die alone.
Statistics Canada, a state agency, and the Society of Obstetricians and Gynaecologists of Canada (SOGC) made the comments after a group wrote to Justin Trudeau, the Canadian prime minister, expressing concern that claims about the country’s treatment of women were being made in the Oireachtas.
Continued at source: https://www.thetimes.co.uk/edition/ireland/canada-responds-to-claims-that-aborted-babies-are-left-to-die-alone-ttpjxxvqh
Long-awaited abortion pill Mifegymiso makes Canadian debut
Kelly Grant - HEALTH REPORTER
The Globe and Mail
Published Friday, Jan. 20, 2017
The abortion pill is finally available in Canada.
The first shipments of Mifegymiso arrived earlier this week at two women’s health clinics in Vancouver and Calgary, marking the beginning of a potential sea change in how women in Canada choose to end their pregnancies.
“We were over the moon,” said Celia Posyniak, the executive director of Calgary’s Kensington Clinic, the first place in the country to provide the medication to a patient. “There’s a few of us who’ve been here for 25 years or more and we’ve been waiting for it for all that time. Canada was definitely a laggard.”
[continued at link]
Source, Globe & Mail: http://www.theglobeandmail.com/news/national/long-awaited-abortion-pill-mifegymiso-rolls-out-in-canada/article33695167/